The Faculty of Medicine Anniversary Thematic Conference on 3 October will be opened by Andrew Epaphroditus Tay, Head of Wellbeing at the National University of Singapore.
A recent overview published by the Estonian Research Council (ETAG) reveals that Estonia has performed exceptionally well in the European Union’s framework programme for research and innovation, Horizon Europe (2021–2027). Among Estonian institutions, the University of Tartu has been the most successful participant in the programme, receiving almost €90 million in funding.
In the genetic study on heart health led by the University of Tartu Estonian Biobank, the required number of participants – just over 2,500 gene donors – have now expressed their willingness to take part. With their help, researchers aim to determine whether heart disease can be more effectively prevented with cholesterol-lowering treatment based on genetic risk assessment.
The UNCAN-Connect project (Decentralized Collaborative Network for Advancing Cancer Research and Innovation), led by the Estonian Cancer Network (ESTCAN) at the University of Tartu, aims to establish an international cancer data sharing platform to facilitate cancer prevention, monitoring, research, and treatment.
On 23 May 2025, Minister of Education and Research Kristina Kallas approved the results of the external evaluation of Estonian research and development. The University of Tartu was the only institution in Estonia to receive a positive evaluation in all six fields: natural sciences, engineering and technology, medical and health sciences, agriculture and veterinary sciences, social sciences, and humanities and the arts.
Ajakirjas The Lancet HIV avaldatud rahvusvaheline uuring toob esile teadmiste lüngad HPV-ga seotud vähi ennetuses HIV-iga elavate inimeste seas ning määratleb vajalikud uurimissuunad tulevikuks.
This is the largest genome-wide association study meta-analysis of its kind, analysing data on 42 female reproductive health diagnoses from the Estonian Biobank and FinnGen.